Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 4 días · Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.

    • Aziz Sancar

      Aziz Sancar, Turkish-American biochemist who contributed to...

    • Thomas R. Cech

      Thomas Robert Cech is an American biochemist and molecular...

    • Paul Modrich

      Paul Modrich (born 1946, Raton, New Mexico, U.S.) is an...

  2. 16 de abr. de 2024 · Jennifer Doudna, whose work on CRISPR earned her the 2020 Nobel Prize in chemistry, applauded the recent approval of a CRISPR-based gene-editing therapy to help those struggling with sickle-cell disease.

  3. 25 de abr. de 2024 · 25 abril, 2024. Jennifer Doudna: Una Vida Marcada por la Pasión y la Ciencia. Este perfil sobre Jennifer Doudna no solo destaca su brillantez y dedicación, sino que también subraya cómo su pasión por la ciencia ha modelado cada aspecto de su vida, ofreciendo valiosas lecciones sobre la importancia de perseguir con fervor aquello que nos mueve.

  4. 17 de abr. de 2024 · Images: Niles Singer/Harvard staff photographer. The world stands on the edge of an era when gene editing can address many serious ills plaguing humankind, according to Jennifer Doudna, whose work on the gene editing technique known as CRISPR-Cas9 earned her the 2020 Nobel Prize in chemistry.

  5. 3 de may. de 2024 · Advancing genome research for a better world. Founded by Nobel Laureate Jennifer Doudna, the Innovative Genomics Institute is using genome engineering to solve humanity’s greatest problems in health, climate, and sustainable agriculture. Read more.

  6. Hace 2 días · Boma Chile, Líder mundial de edición genética Phd. Jennifer Doudna presenta su tecnología CRISPR en programa Transformación 2024 de Boma Chile. Reunion privada y exclusiva.

  7. 6 de may. de 2024 · So far, only about 250 people worldwide have received any kind of experimental CRISPR-based therapies for any disease, said CRISPR pioneer Jennifer Doudna during a recent lecture at HMS. Doudna, who won the 2020 Nobel Prize in chemistry for her work on CRISPR-Cas9, was not involved in the NEJM study.

  1. Otras búsquedas realizadas